Jointly organized by the International Atomic Energy Agency (IAEA), the World Council on Isotopes (WCI) and the Korea Atomic Energy Research Institute (KAERI), the course was designed to transfer crucial knowledge and practical skills to technical professionals in the radiopharmaceutical field, to enable the participants to improve their skills and laboratory capabilities, but also build the leadership skills needed to take up managerial roles in their home countries.
The WCI Secretariat received a total of 67 applications from 31 countries. 8 participants were selected by the Evaluation Committee, based on their scientific background, expectations and potential to contribute to the training course, whilst taking into account the needs of their countries.
The training, which is funded by the WCI and KAERI, included an overview of radiochemistry, radioisotopes, and radiopharmaceuticals with a mix of theoretical lectures and hands-on experience of appropriate techniques. The course took place in several places including Daejeon, Jungeup, and Seoul and included a series of visits to the reactor and manufacturing facility (HANARO Reactor, Samyoung Unitech, KAERI’s Advance Radiation Technology Institute - ARTI), and to the laboratory and hospitals (Seoul National University Hospital, & Asan Medical Center). The participants were able to observe routine practical procedures associated with the whole radiopharmaceutical chain from production to therapeutic application. They were also able to conduct a practical exercise at the ARTI.
Lastly, the WCI Secretariat would like to publicly express its sincere appreciation to Dr. Hyun-Jin Kim of KAERI for his hard work and dedication to make this course a success.
Building on its success, a three-year training program on production and application of radiopharmaceuticals is now planned to take place from next year, which entails a session on the technical aspects (year 1), regulatory aspects (year 2) and workshop on long-term management plan and guideline (year 3). The program will support the capacity for diagnostic and therapeutic radioisotopes and radiopharmaceutical applications in target countries, thereby contributing to improvements at the level of the system and condition.
The 8th WCI Executive Committee Meeting took place in Doha, Qatar